Abstract
Itraconazole (ITZ) solid complex using hydroxypropyl-β-cyclodextrin (ITZ-HP-β-CD) with 20% polyvinylpyrrolidone was prepared by a co-evaporation method. The complex improved antifungal activity against C. parapasilosis and C. albicans. The complex demonstrated good flow and compressibility characteristics. The complex was formulated as a capsule dosage form and drug release was evaluated. Capsules containing ITZ-HP-β-CD at a molar ratio of 1:3 with 20% polyvinylpyrrolidone have a faster dissolution rate than commercial capsules (Sporanox®). About 88% of ITZ was released in less than 30 min and the initial dissolution rate exhibited a 3.5-fold increase compared to the commercial product. UV spectrophotometeric, HPLC, and antimicrobial methods were used to determine ITZ concentration in the release medium and the results obtained by these methods are reported. It was found that HPLC analysis is a suitable and reliable method for determination of the drug concentration with a coefficient of variation less than 10%. The intraday precision showed a coefficient of variation less than 3.96%, and that for interday was less than 4.99%. The HPLC method was more accurate and precise than the antimicrobial and UV-spectrophotometric methods for determination of ITZ concentration present in the release medium.
Similar content being viewed by others
References
Ahmed, M. O., El-Gibaly, I., and Ahmed, S. M., Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Int. J. Pharm., 171, 111–121 (1998).
Alanazi, F. K., Ahmed, S. M., Alhamed, S. S., Mowafy, H. A., Alsarra, I. A., and Bayomi, M. A., Inclusion complexation of Itraconazole with cyclodextrin derivatives: phase solubility and physicochemical characterization. Mansoura J. Pharm. Sci., 23, 177–194 (2007).
Al-Marzouqi, A. H., Elwy, H. M., Shehadi, I., and Adem, A., Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J. Pharm. Biomed. Anal., 49, 227–233 (2009).
Al-Meshal, M. A., Ramadan, M. A., Lotfi, K. M., and Shibl, A. M., Determination of meropenem in plasma by high performance liquid chromatography and a microbioloical method. J. Clin. Pharm. Ther., 20, 159–163 (1995).
Alsarra, I. A., Alanazi, F. K., Alhamed, S. S, Ahmed, S. M, and Mowafy, H. A., Preparation and evaluation of itraconazole-cyclodextrin complexes in solid state. Alex. J. Pharm. Sci., 21, 47–55 (2007).
Amidon, G. L., Lennernäs, H., Shah, V. P., and Crison, J. R., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12, 413–420 (1995).
Ammar, H. O., Salama, H. A., Ghorab, M., and Mahmoud, A. A., Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy. Int. J. Pharm., 320, 53–57 (2006).
Ancarani, F., Incidence and prevalence of Candida nonalbicans in oral Candida infections. Clinician, 11, 6–10 (1993).
Aulton, M. E., Pharmaceutics: The Science of Dosage Form Design. New York, USA, (1988).
Banker, G. S., Anderson, N. R., Tablets, In Lachman, L., Liberman, H. A., and Kanig, J. I. (Eds.), The Theory and Practice of Industrial Pharmacy. Lea and Febiger, Philadelphia, pp. 293–345, (1986).
Bettinetti, G. P., Mura, P., Liguori, A., Bramanti, G., and Giordano, F., Solubilization and interaction of naproxen with cyclodextrins in aqueous solution and in the solid state. Farmaco Prat., 43, 331–343 (1988).
Brewster, M. E., Vandecruys, R., Peeters, J., Neeskens, P., Verreck, G., and Loftsson, T., Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutyletherbeta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions. Eur. J. Pharm. Sci., 34, 94–103 (2008).
Cappello, B., De Rosa, G., Giannini, L., La Rotonda, M. I., Mensitieri, G., Miro, A., Quaglia, F., and Russo, R., Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: Potential as buccal delivery system. Int. J. Pharm., 319, 63–70 (2006).
Cirri, M., Maestrelli, F., Corti, G., Furlanetto, S., and Mura, P., Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization. J. Pharm. Biomed. Anal., 42, 126–131 (2006).
De Beule, K. and Gestel, J. V., Pharmacology of itraconazole. Drugs, 61, 27–37 (2001).
Dupont, B. and Drouhet, E., Early experience with itraconazole in vitro and in patients: Pharmacokinetic studies and clinical results. Rev. Infect. Dis., 9, S71–S76 (1987).
El-Maradny, H. A., Mortada, S. A., Kamel, O. A., and Hikal, A. H., Characterization of ternary complexes of meloxicam-HP β CD and PVP or L-arginine prepared by the spray-drying technique. Acta Pharm., 58, 455–466 (2008).
Espinel-Ingroff, A., Shadomy, S., and Gebhart, R. J., In vitro studies with R 51,211 (Itraconazole). Antimicrob. Agents Chemother., 26, 5–9 (1984).
Farmaki, E., Evdoridou, J., Pouliou, T., Bibashi, E., Panagopoulou, P., Filioti, J., Benos, A., Sofianou, D., Kremenopoulos, G., and Roilides, E., Fungal colonization in the neonatal intensive care unit: risk factors, drug susceptibility, and association with invasive fungal infections. Am. J. Perinatol., 24, 127–135 (2007).
Fromtling, R. A., Galgiani, J. N., Pfaller, M. A., Espinel-Ingroff, A., Bartizal, K. F., Bartlett, M. S., Body, B. A., Frey, C., Hall, G., Roberts, G. D., Nolte, F. B., Odds, F. C., Rinaldi, M. G., Sugar, A. M., and Villareal, K., Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother., 37, 39–45 (1993).
Gennaro, A. R., Der Marderosian, A. H., Hanson, G. R., and Medwick, T., Remington: The Science and Practice of Pharmacy. Philadelphia, USA, (2000).
Gubbins, P. O., Gurley, B. J., and Bowman, J., Rapid and sensitive high performance liquid chromatographic method for determination of itraconazole and hydroxy-metabolite in human serum. J. Pharm. Biomed. Anal., 16, 1005–1012 (1998).
Hassan, H. A., Al-Marzouqi, A. H., Jobe, B., Hamza, A. A, and Ramadan, G. A., Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide. J. Pharm. Biomed. Anal., 45, 243–250 (2007).
Hegde, R. P., Rheingold, J. L., Welch, S., and Rhodes, C. T., Studies of powder flow using a recording powder flow-meter and measurement of the dynamic angle of repose. J. Pharm. Sci., 74, 11–15 (1985).
Hikal, A. H., Shibl, A., and El-Houfy, S., Determination of sodium fusidate and fusidic acid in dosage forms by high performance liquid chromatography and a microbiological method. J. Pharm. Sci., 71, 1297–1298 (1982).
Hostetler, J. S., Heykants, J., Clemons, K. V., Woestenborghs, R., Hanson, L. H., and Stevens, D. A., Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: Studies of interpatient variations in concentrations. Antimicrob. Agents Chemother., 37, 2224–2227 (1993).
Hufford, C. D., Funderburk, M. J, Morgan, J. M., and Robertson, L. W., Two antimicrobial alkaloids from heartwood of Liriodendron tulipifera L. J. Pharm. Sci., 64, 789–792 (1975).
Hwang, C.-C. and Lee, W.-C., Chromatographic resolution of the enantiomers of phenylpropanolamine by using molecularly imprinted polymer as the stationary phase. J. Chromatogr. B Biomed. Sci. Appl., 765, 45–53 (2001).
Jung, J. Y., Yoo, S. D., Lee, S. H., Kim, K. H., Yoon, D. S., and Lee, K. H., Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int. J. Pharm., 187, 209–218 (1999).
Khan, K. A., The concept of dissolution efficiency. J. Pharm. Pharmacol., 27, 48–49 (1975).
Loftsson, T. and Brewster, M. E., Pharmaceutical applications of cyclodextrins. I. Drug solubilization and stabilization. J. Pharm. Sci., 85, 1017–1025 (1996).
Miro, A., Quaglia, F., Giannini, L., Cappello, B., and La Rotonda, M. I., Drug/cyclodextrin solid systems in designing hydrophilic matrices: A strategy to modulate drug delivery rate. Curr. Drug Deliv., 3, 373–378 (2006).
Miyake, K., Irie, T., Arima, H., Hirayama, F., Uekama, K., Hirano, M., and Okamaoto, Y., Characterization of itraconazole/ 2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm., 179, 237–245 (1999).
Mura, P., Bettinetti, G., Melani, F., and Manderioli, A., Interaction between naproxen and chemically modified β-cyclodextrins in the liquid and solid state. Eur. J. Pharm. Sci., 3, 347–355 (1995).
Mura, P., Faucci, M. T., and Bettinetti, G. P., The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci., 13, 187–194 (2001).
Ng, T. K., Chan, R. C., Adeyemi-Doro, F. A., Cheung, S. W., and Cheng, A. F., Rapid high performance liquid chromatographic assay for antifungal agents in human sera. J. Antimicrob. Chemother., 37, 465–472 (1996).
Peeters, J., Neeskens, P., Tollenaere, J. P., van Remoortere, P., and Brewster, M. E., Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7. J. Pharm. Sci., 91, 1414–1422 (2002).
Raghavan, S. L., Schuessel, K., Davis, A., and Hadgraft, J., Formation and stabilization of triclosan colloidal suspension using supersaturated systems. Int. J. Pharm., 261, 153–158 (2003).
Rao, V. M., Nerurkar, M., Pinnamaneni, S., Rinaldi, F., and Raghavan, K., Co-solubilization of poorly soluble drugs by micellization and complexation. Int. J. Pharm., 319, 98–106 (2006).
Reeves, D. S., Wise, R., Andrews, J. M., and White, L. O., Clinical Antimicrobial Assays. Oxford, (1999).
Rodriguez-Hornedo, N. and Murphy, D., Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J. Pharm. Sci., 88, 651–660 (1999).
Serajuddin, A. T., Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci., 88, 1058–1066 (1999).
Shibl, A. M., Tawfik, A. F., El-Houfy, S., and Al-Shammary, F. J., Determination of lomefloxacin in biological fluids by high performance liquid chromatography and a microbioloical method. J. Clin. Pharm. Ther., 16, 353–359 (1991).
Shim, S. Y., Ji, C. W., Sah, H., Park, E. S., and Lee, B. J., Characterization of itraconazole semisolid dosage forms prepared by hot melt technique. Arch. Pharm. Res., 29, 1055–1060 (2006).
Six, K., Daems, T., de Hoon, J., Van Hecken, A., Depre, M., Bouche, M. P., Prinsen, P., Verreck, G., Peeters, J., Brewster, M. E., and van den Mooter, G., Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion. Eur. J. Pharm. Sci., 24, 179–186 (2005).
Strickley, R. G., Solubilizing excipients in oral and liquid formulations. Pharm. Res., 21, 201–230 (2004).
Truant, A. L., Manual of Commercial Methods in Clinical Microbiology. Virginia, USA, (2002).
Valero, M., Pérez-Revuelta, B.I., and RodrÍguez, L. J., Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex. Int. J. Pharm., 253, 97–110 (2003).
van Doorne, H. and Bosch, E. H., Stability and in vitro activity of nystatin and its γ-cyclodextrin complex against Candida albicans. Int. J. Pharm., 73, 43–49 (1991).
Venkateswarlu, K., Denning, D. W., and Kelly, S. L., In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei. J. Antimicrob. Chemother., 39, 731–736 (1997).
Warnock, D. W., Turner, A., and Burke, J. Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole J. Antimicrob. Chemother., 21, 93–100 (1988).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alsarra, I.A., Alanazi, F.K., Ahmed, S.M. et al. Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product. Arch. Pharm. Res. 33, 1009–1017 (2010). https://doi.org/10.1007/s12272-010-0706-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0706-3